Theravance, Inc. (NASDAQ:THRX)

Bull and Bear

Top Analyst Upgrades and Downgrades: AMD, Gap, Priceline, SanDisk and Many More

We are in the thick of corporate earnings season and stocks are challenging all-time highs. This is a climate in which investors want and need to know which stocks to ...
Read Full Story »
stock symbol ticker

Market Close: Big Winners & Losers for April 18, 2013

Here are today’s five biggest gaining stocks at closing: Overstock.com (NASDAQ: OSTK) is up 37% at $15.70. Adcare Health Systems Inc. (NYSEMKT: ADK) is up 36.7% at $5.88. Primus Telecommunications ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Positive Views from Wall Street

Investors are on the hunt for fresh research ideas that will lead to higher income or more profits. Each and every morning we review many fresh research calls from Wall ...
Read Full Story »
stock symbol ticker

Market Close: Big Winners & Losers for April 15, 2013 (GENE, THRX, SGRP, MAGS, CNIT, UNTK, GSS, DSCO, HXM, ECTY)

Here are today’s five biggest gaining stocks at closing: Genetic Technologies Ltd. (NASDAQ: GENE) is up 22.8% at $2.75. Theravance Inc. (NASDAQ: THRX) is up 19.4% at $28.36. Spar Group ...
Read Full Story »
biotech

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Big biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. ...
Read Full Story »
biotech

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from ...
Read Full Story »

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the ...
Read Full Story »

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in ...
Read Full Story »

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it ...
Read Full Story »

Theravance Jumps on Glaxo Investment (THRX, GSK)

Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc (NYSE: GSK) at a 7.5% premium to a volume-weighted average ...
Read Full Story »

24/7 Wall St. Closing Bell (COST, XOM, AKAM, P, SCCO, MRK, AYI, CBST, AA, INHX, PSOF, IDIX, NFLX, THRX, LTRX)

US markets opened up slightly this morning and have maintained a slight positive tone for most of the day. Today marks the unofficial beginning of another earnings season, with Alcoa ...
Read Full Story »

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each ...
Read Full Story »

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

2010 is ending and 2011 is about to begin.  It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there ...
Read Full Story »

Best BioHealth Stocks of 2010, Outlook for 2011 (JAZZ, DNDN, HGSI, ARIA, AMRN, NBIX, THRX)

2010 has been an interesting year in biotech and in biohealth stocks, even if it has lacked some of the ten-baggers that were seen in 2009.  In 2009, companies like ...
Read Full Story »

Top 10 Analyst Upgrades and Downgrades (BKD, EOG, ITRI, K, PTEN, PEET, PGR, THRX, VALE, VRSN)

These are this Monday's top ten analyst upgrades and downgrades seen from Wall Street research calls: Brookdale Senior Living Inc. (NYSE: BKD) Removed from Goldman Sachs Conviction Buy List. EOG ...
Read Full Story »